This is an Open-labeled, Randomized, Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of Booster Dose of Sabin Strain Inactivated Poliovirus Vaccine (Vero cell) (sIPV) Co-administered with Measles, Mumps, Rubella (MMR) Combined Live Attenuated Vaccine and Inactivated Hepatitis A (Hep-A) Vaccine.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
seroconversion rates (SCRs) of sIPV neutralizing antibody against different poliovirus serotypes (Type I, II and III)
Timeframe: 30 days
SCRs of anti-meascles IgG antibodies
Timeframe: 30 days
SCRs of anti-mumps IgG antibodies
Timeframe: 30 days
SCRs of anti-rubella IgG antibodies
Timeframe: 30 days
SCRs of anti-hepatitis A IgG antibodies
Timeframe: 30 days